All lobbying filings
W Strategies, LLC
W Strategies, LLC filed a Q4 report for Ipsen Biopharmaceuticals, Inc. on January 20, 2026, reporting $20,000 in lobbying income.
Lobbying for Ipsen Biopharmaceuticals, Inc. · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbying activity
1
Monitored Public Law 119-21: One Big Beautiful Bill Act.